OsoBio Appoints Lindsey Pruitt to Manage East Coast
Albuquerque, NM Jul 22, 2013 – OsoBio has named Lindsey Pruitt manager of new business development for its East Coast market.
Working in her new capacity in OsoBio’s Philadelphia location, Pruitt will identify and foster new business opportunities throughout the Northeast.
Pruitt has worked nearly a decade in sales and marketing within the pharmaceutical and specialty chemical manufacturing industries.
Most recently, she served as manager of commercial operations and sales for Siegfried USA, a manufacturer of active pharmaceutical ingredients (APIs). There, she was responsible for managing key accounts and serving as the primary customer contact from research and development to commercial product launch.
“Lindsey shows a real passion for working in partnership with OsoBio’s clients to deliver life-saving pharmaceuticals to the patients who need them,” said Milton Boyer, president of OsoBio. “She will demonstrate for clients the value OsoBio can bring as the contract manufacturer of choice for their sterile injectable needs.”
Pruitt graduated cum laude from Lee University with a bachelor’s degree in psychology and advanced studies in microbiology and chemistry.
OSO BioPharmaceuticals Manufacturing, LLC, is a contract manufacturing organization (CMO) that specializes in delivering injectable sterile liquid, suspension and lyophilized biologic and pharmaceutical products to the pharmaceutical industry. Our company offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization.
In the history of our Albuquerque, N.M., facility, OsoBio has manufactured more than 250 distinct commercial presentations in every major therapeutic category. The U.S. Drug Enforcement Administration (DEA) has granted OsoBio registrations for Schedule II through V controlled substances.